CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC).
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Massachusetts General Hospital, Duke University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of North Carolina at Chapel Hill, University of Chicago Medical Center, University of Pittsburgh Medical Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2603225534